title: Preliminary use of a hydrogel containing enzymes in the treatment of stage II and stage III pressure ulcers.
abstract: Considerable progress has been made in the prevention and treatment of pressure ulcers but they remain a significant healthcare problem, particularly among the elderly. Treatment may include the use of wound dressings such as hydrogels as well as debridement products that contain relatively high concentrations of various enzymes. Unlike enzymes found in debridement products, low concentrations of endopeptidase enzymes can cleave to denatured proteins. Many endopeptidases have been reported to enhance the healing process. To evaluate the effect of a hydrogel wound dressing containing a combination of endopeptidases on pressure ulcers, a 12-week prospective preliminary study was conducted involving 10 nursing home patients with Stage II (n = 3) or Stage III (n = 7) ulcers that had failed to respond to previous treatments. Seven subjects (three with Stage II ulcers and four with Stage III ulcers) completed the study. Healing was based on wound closure by re-epithelialization as determined by area measurement and clinical assessment. All three Stage II ulcers and two of the Stage III ulcers healed completely; four Stage III ulcers were categorized as healing (>60% improvement) after 12 weeks of care. No dressing-related adverse events occurred and subject acceptance of the product, including comfort, was high. These results suggest that additional studies designed to define the possible contribution of endopeptidase enzymes in wound healing are warranted.
authors.affiliation: Precision Consulting, 6522 Harbor Mist, Missouri City, TX 77459-3083, USA. l-parnell@earthlink.net
authors.forename: Linda K S
authors.initials: LK
authors.lastname: Parnell
authors.forename: Brandi
authors.initials: B
authors.lastname: Ciufi
authors.forename: Charles F
authors.initials: CF
authors.lastname: Gokoo
mesh_terms: D000368:Aged; D047070:Bandages, Hydrocolloid / Q000592:standards*; D003646:Debridement / Q000379:methods; D010450:Endopeptidases / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006097:Granulation Tissue / Q000187:drug effects; D006701:Home Nursing; D006801:Humans; D008297:Male; D009730:Nursing Assessment; D003668:Pressure Ulcer / Q000145:classification / Q000628:therapy*; D011446:Prospective Studies; D012720:Severity of Illness Index; D017592:Skin Care / Q000295:instrumentation / Q000379:methods* / Q000451:nursing; D013997:Time Factors; D016896:Treatment Outcome; D014945:Wound Healing / Q000187:drug effects
chemical_list: D010450:Endopeptidases